Skip to main content
TipRanks
Go Ultimate75% OFF

Simcere Pharmaceutical Group Limited (2096) Income Statement

4 Followers

Simcere Pharmaceutical Group Limited Income Statement

Last quarter (Q2 2026), Simcere Pharmaceutical Group Limited's total revenue was ¥4.52B, an increase of 45.07% from the same quarter last year. In Q2, Simcere Pharmaceutical Group Limited's net income was ¥817.28M. See Simcere Pharmaceutical Group Limited’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 7.73B¥ 6.64B¥ 6.61B¥ 6.32B¥ 5.00B
¥ 6.31B¥ 5.32B¥ 4.98B¥ 5.00B¥ 3.92B
¥ 4.75B¥ 4.48B¥ 4.27B¥ 4.14B¥ 2.47B
Depreciation and Amortization¥ 380.83M¥ 337.86M¥ 309.59M¥ 283.65M¥ 251.81M
¥ 1.80B¥ 1.47B¥ 1.08B¥ 889.99M¥ 485.14M
¥ 1.56B¥ 848.05M¥ 711.80M¥ 862.50M¥ 1.45B
¥ -41.16M¥ -28.17M¥ 28.24M¥ 25.65M¥ -46.75M
¥ 1.51B¥ 819.88M¥ 740.04M¥ 888.15M¥ 1.40B
¥ 1.34B¥ 733.16M¥ 714.76M¥ 930.87M¥ 1.51B
Per Share Metrics
Basic EPS¥ 0.54¥ 0.29¥ 0.27¥ 0.36¥ 0.58
Diluted EPS¥ 0.54¥ 0.29¥ 0.27¥ 0.36¥ 0.58
Weighted Average Shares Outstanding2.49B2.52B2.61B2.61B2.61B
Weighted Average Shares Outstanding (Diluted)2.49B2.52B2.61B2.62B2.61B

Currency in CNY

Simcere Pharmaceutical Group Limited Earnings and Revenue History

03B6B9B8 %16 %24 %32 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin